IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation. - Wikidata - wikimedia - TriplyDB

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q33816022

about

Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.

P2860

Q47578102-161EF471-0974-4F5E-A3BC-977D6EF5145F Q55096330-8B7EB110-B2F2-4F50-A01B-4C544117FA8F

P2860

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q33816022

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@ast

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@en

type

label

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@ast

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@en

prefLabel

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@ast

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@en

P1433

Q33816022-08E18A08-FC3D-485E-A528-F38FA4DFA3A0

P1476

Q33816022-BFC137D8-7799-464E-ACDD-84D4C8308507

P2093

Q33816022-054A0A9D-DE14-4D36-8ABE-CCC09154D9A7

Q33816022-07C1658D-C6FC-49CA-A201-2BBA927B471E

Q33816022-1C9692C6-C749-4726-9E7B-11EEA1BD7CC9

Q33816022-1E851C17-619B-41DB-BAB4-035B5D1E4473

Q33816022-2547EB05-E14B-4B9E-975A-F4D25DC807E9

Q33816022-286C96B8-24C9-4CC8-9520-D5E3659EC5A9

Q33816022-36A4DB4E-79F0-4221-8138-E871052C1993

Q33816022-435CCF31-1AE8-4EF8-867D-30290549BE85

Q33816022-50D26B83-EA96-4535-97C4-752CCC2A15B2

Q33816022-52525F86-3330-4226-88CC-C89F6A13E507

P2860

Q33816022-06045E92-AFAF-4D0E-AC1B-39A51C3C7E64

Q33816022-0D59937D-9F0C-4DC1-B50E-D154084DB4DF

Q33816022-0F2CA663-D8C5-46AA-9D45-AA89AB15D0B9

Q33816022-16330FC8-6C9A-42D9-8891-EB9E31890EA5

Q33816022-28434F08-BA34-45C4-9D62-D102D279800A

Q33816022-40D2650C-4FF2-4943-8755-7E2661308349

Q33816022-422577A6-1694-446A-BF1C-E697CDAC54FE

Q33816022-44E81A42-5539-4BA3-B0CB-E64993AD3BA5

Q33816022-4883F4B5-8C8D-4145-95FD-05A233114A57

Q33816022-4901D82F-FA3F-44E7-A7C0-7E72010D7A15

P304

Q33816022-256B7C6D-9A93-4AD1-AF70-9B9FED446FDE

P31

Q33816022-BFBB6CBD-6355-41E6-AED2-FE308352F694

P356

Q33816022-CFD36E84-B1FB-4396-9E4A-4C6992CFE74E

P433

Q33816022-2CB90CD8-97EA-40D5-B5B4-F1C368C15323

P478

Q33816022-A711AEAC-8E52-4577-B7BA-E2F1564B52AB

P577

Q33816022-2749D8CC-9D7C-443E-B457-1ED4F4E858C7

P698

Q33816022-543CC9A8-BF29-486B-9922-079799836E47

P932

Q33816022-19EC0334-ABF5-4D42-90AA-445D18B8BFC7

P356

HAEMATOL.2016.153072

P1433

P1476

IL-2 promotes early Treg recon ...... opoietic cell transplantation.

@en

P2093

Asmita Mishra

http://www.w3.org/2001/XMLSchema#string

Brian C Betts

http://www.w3.org/2001/XMLSchema#string

Claudio Anasetti

http://www.w3.org/2001/XMLSchema#string

Divis K Khaira

http://www.w3.org/2001/XMLSchema#string

Ernesto Ayala

http://www.w3.org/2001/XMLSchema#string

Farhad Khimani

http://www.w3.org/2001/XMLSchema#string

Frederick L Locke

http://www.w3.org/2001/XMLSchema#string

Hugo Fernandez

http://www.w3.org/2001/XMLSchema#string

Jongphil Kim

http://www.w3.org/2001/XMLSchema#string

Jose Leonel Ochoa-Bayona

http://www.w3.org/2001/XMLSchema#string

P2860

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.

Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells.

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation

CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.

P304

948-957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2016.153072

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28104702

http://www.w3.org/2001/XMLSchema#string

P932

5477614

http://www.w3.org/2001/XMLSchema#string